Survodutide 10mg (10 vials kit) Stealth Labs
€1,260.00
General introduction and principle of operation (Survodutide 10mg (10 vials kit) Stealth Labs)
Survodutide, an innovative formulation developed by Stealth Labs, is aimed at promoting healthy glycemic control and weight management. This comprehensive kit comprises ten vials, each containing 10 mg of the active substance Survodutide, also known as Tirzepatide. As a glucagon-like peptide-1 (GLP-1) receptor agonist, it synergistically enhances insulin sensitivity and secretion while reducing appetite. This multifaceted approach makes it a valuable option for individuals seeking effective management of blood glucose levels. The principle of operation involves mimicking natural gut hormones to regulate metabolism and support weight loss in a clinical setting.
Main components and active substances
The efficacy of Survodutide stems from its unique composition and the mechanisms of its active ingredients. Understanding these components is essential for users aiming to leverage its benefits. The following elements are crucial for its effectiveness:
- Survodutide (Tirzepatide): The primary active ingredient known for regulating blood sugar levels.
- Buffering agents: Critical for stabilizing the solution and ensuring consistent delivery in a clinical setting.
- Preservatives: Added to maintain the integrity and efficacy of the formulation over time.
- Solvent: Ensures the optimal delivery of Survodutide into the body.
- Storage components: Formulated to maintain stability, especially when refrigerated, preventing degradation.
Mechanisms of action and expected results
Survodutide operates through well-documented biological mechanisms designed to improve glycemic control and promote weight loss. Understanding these mechanisms helps users anticipate the desired outcomes associated with its therapeutic use. Key factors include:
- GLP-1 receptor stimulation: This action enhances insulin secretion from the pancreas, particularly after meals.
- Appetite suppression: By acting on central nervous system receptors, it reduces hunger sensation, fostering a caloric deficit.
- Gastric emptying delay: Slows down the digestion process, which helps maintain stable blood sugar levels.
- Increased energy expenditure: Encourages metabolism optimization and enhances fat oxidation.
Recommendations for use
For optimal results with Survodutide, users should adhere to specific guidelines concerning administration and lifestyle adjustments. Consider the following recommendations:
- Dosage initiation: It is advisable to start with 2.5 mg, gradually increasing based on individual response.
- Regular monitoring: Users should regularly track blood glucose levels to assess the medication’s effectiveness.
- Dietary adjustments: Integrating a balanced diet can further support glycemic control and weight management.
- Consult healthcare professionals: It’s essential to seek medical advice to tailor the treatment to your specific needs.
Possible risks and contraindications (Survodutide 10mg (10 vials kit) Stealth Labs)
While Survodutide is designed to be effective, it’s crucial for users to be aware of potential risks and contraindications associated with its use. Users should consider the following:
- Side effects: Commonly reported adverse effects include nausea, diarrhea, and a decreased appetite.
- Medical conditions: Individuals with a personal or family history of medullary thyroid carcinoma should avoid use.
- Drug interactions: Consulting a healthcare provider is essential to avoid contraindicated medications.
- Pregnancy and breastfeeding: Safety during pregnancy and lactation has not been established, caution is advised.
| Active substance | Survodutide |
|---|---|
| Hepatotoxicity | No significant hepatotoxicity reported |
| Lab Test | Monitoring blood glucose levels and HbA1c |
| Also known as | LY3298176 |
| Blood pressure | May reduce blood pressure |
| Trade name | Mounjaro |
| FORM | 10 vials x 10 mg |
| Storage conditions | Store in a refrigerator at 2В°C to 8В°C (36В°F to 46В°F), protect from light |
| Chemical name | Tirzepatide |
| Formula | C225H348N48O68 |
| Substance class | Glucagon-like peptide-1 (GLP-1) receptor agonists |
| Main action | Lowers blood glucose levels |
| Half-life | Approximately 5 days |
| Dosage (medical) | Typically started at 2.5 mg once weekly, can be increased to 5 mg, 10 mg, or 15 mg once weekly depending on response and tolerability |
| Dosage (sports) | Not applicable as it is not used for performance enhancement |
| Effects | Improves glycemic control, promotes weight loss |
| Side effects | Nausea, diarrhea, decreased appetite, vomiting, constipation |
| Use in sports | None, not used for performance enhancement |
| Manufacturer | Stealth Labs |
| 5 |
|
0 |
| 4 |
|
0 |
| 3 |
|
0 |
| 2 |
|
0 |
| 1 |
|
0 |


Reviews
There are no reviews yet.